Zhu Hongwen, Ph.D., doctoral supervisor, chief physician, chief scientist, Tianjin Thousand Talents Program Leader Incoming talents, specially-appointed experts in Tianjin.

Currently Operas (Beijing) Technology Co., Ltd. and Tianjin Fuhua Medical Technology Co., Ltd. Chairman and CEO. Graduated from Tianjin Medical University, worked in Tianjin Hospital for 8 years and went to study in the United States; graduated from Albert Einstein College of Medicine with a Ph.D. in Neuroscience. Scientist and Senior at the Cell Therapy Center at Columbia University School of Medicine Scientists and Chief ScientistsScientists.

Won the title of Tianjin Thousand Talents Program and Tianjin Distinguished Expert in 2012; returned to China in 2013 as deputy of Tianjin Hospital President, Vice President of Tianjin Joint Institute of Traditional Chinese and Western Medicine; Chief Physician; Doctor of Surgery (Orthopedics), Tianjin Medical University guide.

Former Vice President of BOE Technology Group Co., Ltd., CTO of Health Business Group (HBG) and Medical Technology Researcher Dean of the Institute.

2013 Li Heritage Foundation's highest award: Outstanding Contribution Award (Li Heritage Foundation Prize for Excellent Achievement).

Current member of the North American Neurological Society; member of the New York Academy of Sciences; North American SpineMember of the Society of Surgery; Editorial board of “Orthopaedic Surgery”). In recent years, he has been mainly engaged in research work in the field of innovation, in orthopedic reduction robots, bionic artificial joints, bionic spine He has applied for more than 30 patents in fixed and other fields. The orthopaedic bone-setting robot project won the 2014 Chunhui Cup Greater New Yorkthe first prize in the competition area; 2015 "Kobo Rising Star" (Corp Starter)" first place in the North American Entrepreneurship Competition.